Murdoch D R, Rooney E, Dargie H J, Shapiro D, Morton J J, McMurray J J
Department of Cardiology, Western Infirmary, Dumbarton Road, Glasgow G11 6NT, UK.
Heart. 1999 Sep;82(3):352-6. doi: 10.1136/hrt.82.3.352.
Cardiac cachexia is a syndrome of generalised wasting which caries a poor prognosis and is associated with raised plasma concentrations of tumour necrosis factor alpha (TNFalpha). TNFalpha increases secretion of leptin, a hormone which decreases food intake and increases energy expenditure.
To determine whether an inappropriate increase in plasma leptin concentration contributes to the cachexia of chronic heart failure.
Retrospective case-control study.
Tertiary referral cardiology unit.
110 human subjects comprising 29 cachectic chronic heart failure patients, 22 non-cachectic chronic heart failure patients, 33 patients with ischaemic heart disease but normal ventricular function, and 26 healthy controls.
Measurement of: body fat content by skinfold thickness (cachectic males < 27%, females < 29%); plasma leptin, TNFalpha, and noradrenaline (norepinephrine); central haemodynamics in chronic heart failure patients at right heart catheterisation.
Plasma leptin concentration corrected for body fat content, plasma TNFalpha and noradrenaline concentration, and central haemodynamics.
Mean (SEM) plasma leptin concentrations were: 6.2 (0.6) ng/ml (cachectic heart failure), 16.9 (3.6) ng/ml (non-cachectic heart failure), 16.8 (3.0) ng/ml (ischaemic heart disease), and 18.3 (3.5) ng/ml (control) (p < 0.001 for cachectic heart failure v all other groups). Plasma leptin concentration remained significantly lower in the cachectic heart failure group even after correcting for body fat content and in spite of significantly increased TNFalpha concentrations. Thus plasma leptin was inappropriately low in cachectic chronic heart failure in the face of a recognised stimulus to its secretion. There was no significant correlation between plasma leptin, New York Heart Association class, ejection fraction, or any haemodynamic indices.
Leptin does not contribute to the cachexia of chronic heart failure. One or more leptin suppressing mechanisms may operate in this syndrome-for example, the sympathetic nervous system.
心脏恶病质是一种全身性消耗综合征,预后较差,且与血浆肿瘤坏死因子α(TNFα)浓度升高有关。TNFα会增加瘦素的分泌,瘦素是一种可减少食物摄入并增加能量消耗的激素。
确定血浆瘦素浓度的不适当升高是否会导致慢性心力衰竭的恶病质。
回顾性病例对照研究。
三级转诊心脏病科。
110名受试者,包括29名恶病质性慢性心力衰竭患者、22名非恶病质性慢性心力衰竭患者、33名缺血性心脏病但心室功能正常的患者以及26名健康对照者。
通过皮褶厚度测量体脂含量(恶病质男性<27%,女性<29%);测量血浆瘦素、TNFα和去甲肾上腺素;对慢性心力衰竭患者进行右心导管检查时测量中心血流动力学。
校正体脂含量后的血浆瘦素浓度、血浆TNFα和去甲肾上腺素浓度以及中心血流动力学。
平均(SEM)血浆瘦素浓度分别为:6.2(0.6)ng/ml(恶病质性心力衰竭)、16.9(3.6)ng/ml(非恶病质性心力衰竭)、16.8(3.0)ng/ml(缺血性心脏病)和18.3(3.5)ng/ml(对照组)(恶病质性心力衰竭与所有其他组相比,p<0.001)。即使校正体脂含量后,恶病质性心力衰竭组的血浆瘦素浓度仍显著较低,尽管TNFα浓度显著升高。因此,在存在公认的瘦素分泌刺激因素的情况下,恶病质性慢性心力衰竭患者的血浆瘦素水平仍不适当降低。血浆瘦素与纽约心脏协会心功能分级、射血分数或任何血流动力学指标之间均无显著相关性。
瘦素不会导致慢性心力衰竭的恶病质。在该综合征中可能存在一种或多种抑制瘦素的机制,例如交感神经系统。